Results 51 to 60 of about 11,011 (206)

Using a NanoBRET‐Based Ligand‐Binding Assay at the β2‐Adrenoceptor for Undergraduate Pharmacology Education

Pharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.
ABSTRACT The teaching of pharmacology includes a fundamental understanding of ligand binding; how it is measured and how it is calculated. We sought to modernize the techniques by which ligand affinity is determined by undergraduate students and introduce them to parameter estimation through curve fitting.
Abigail Pearce, Xianglin Huang, Theo Redfern‐Nichols, Claudia M. Sisk, Dewi Safitri, Michael Collins, Milena A. Malcharek, Sergio Tomey García, Chiharu Nakamura, Andrzej Harris, Graham Ladds   +10 more
wiley   +1 more source

Formoterol for the Treatment of Chronic Obstructive Pulmonary Disease

International Journal of COPD, 2020
Donald P Tashkin Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USACorrespondence: Donald P TashkinDavid Geffen School of Medicine at UCLA, 10388 Le Conte Avenue, Los Angeles, CA 90095, USATel +1 310 825 3163Fax +1 310 ...
Tashkin DP
doaj  

Electrochemical Studies of Expired Drug (Formoterol) as Oilfield Corrosion Inhibitor for Mild Steel in H2SO4 Media

International Journal of Electrochemical Science, 2020
The expired drug Formoterol (EDF) [N-(2-hydroxy-5-(1-hydroxy-2-((1-(4-methoxyphenyl)propan-2-yl)amino)ethyl)phenyl)formamide] was examined as potential corrosion inhibitor of mild steel in 1 M sulphuric acid (H2SO4) media using weight loss ...
Xiangrong Ma, Rui Dang, Yuhong kang, Ying Gong, Jiao Luo, Yuanyuan Zhang, Jiawei Fu, Chunyan Li, Yajun Ma   +8 more
doaj   +1 more source

Clinical utility and development of the fluticasone/formoterol combination formulation (Flutiform®) for the treatment of asthma

Drug Design, Development and Therapy, 2014
Ricardo Antonio Tan,1 Jonathan Corren2 1California Allergy and Asthma Medical Group, 2David Geffen School of Medicine at UCLA, Los Angeles, CA, USAAbstract: Pharmacologic treatment of asthma should be done with a stepwise approach recommended in ...
Tan RA, Corren J
doaj  

Long-acting beta2-agonists for chronic obstructive pulmonary disease.

, 2013
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a respiratory disease that causes progressive symptoms of breathlessness, cough and mucus build-up.
Walters, JA, Chris Mavergames, Kew, KM, Mavergames, C, Kayleigh M Kew, Julia AE Walters   +5 more
core   +1 more source

Molecular Clocks in Translational Roadmap for Circadian‐Based Therapeutics in Lung Diseases

The FASEB Journal, Volume 40, Issue 10, 31 May 2026.
High‐amplitude circadian oscillations maintain lung immune and epithelial homeostasis. Chronic inflammation dampens peripheral clock amplitude, driving chronodisruption, barrier dysfunction, and remodeling. Clock‐targeted therapies re‐entrain the lung circadian clock, restore rhythmic immune resolution, and promote functional lung repair.
Kingshuk Panda, Renu Khasa, Srinivasan Chinnapaiyan, Saurabh Aggarwal, Irfan Rahman, Hoshang Unwalla   +5 more
wiley   +1 more source

Comparing the immediate Bronchodilatory effects of Salbutamol versus Formoterol: A General Practice Study in Patients with Moderate Asthma

South African Family Practice, 2001
Objectives: To determine whether there is significant difference in the onset of bronchodilatory action between salbutamol, a short-acting beta-2 stimulant and formoterol, a long-acting beta-2 stimulant.
C.M. Kruger
doaj   +1 more source

Biological actions of formoterol isomers

, 2002
Racemic β2 agonists, composed of equal amounts of (R)- and (S)-isomers, can display anomalous actions that compromise their effectiveness as asthma therapies.
Senanayake, Chris H,, Handley, Dean A.,, Dutczak, William,, Andersson, Rolf,, Wilkinson, H. Scott,, Morley, John,, Johansson, Fredrik,, Walle, Thomas,, Penn, Raymond B.,, Benovic, Jeffrey L,, Tanoury, Gerald J.,   +10 more
core   +1 more source

Evaluation of Small Airways Dysfunction With Dupilumab Using Airway Oscillometry in Uncontrolled Severe Asthma

Clinical &Experimental Allergy, Volume 55, Issue 3, Page 264-266, March 2025.
Kirsten E. Stewart, Chris RuiWen Kuo, Rory Chan, Brian J. Lipworth   +3 more
wiley   +1 more source

Horizontal Heart Orientation as a Mechanistic Contributor to Platypnea–Orthodeoxia Syndrome in Patent Foramen Ovale

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Altered cardiac orientation in the presence of a patent foramen ovale (PFO) can contribute to platypnea–orthodeoxia syndrome (POS) and unexplained hypoxemia. In such cases, consideration of PFO closure may lead to significant clinical improvement.
Bijeta Keisham, Sanchit Duhan, Uday B. Kanakadandi, Osama Alsara, Naveed A. Adoni, Sanjay S. Mehta, Andrea Brasch, Haseeb Basha, Vishesh Paul   +8 more
wiley   +1 more source